https://www.live-feeds.com/feed/moderna-s-ceo-gives-an-inside-look-at-the-biotech-s-new-eraContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/moderna-s-ceo-gives-an-inside-look-at-the-biotech-s-new-erahttps://www.live-feeds.com/feed/moderna-s-ceo-gives-an-inside-look-at-the-biotech-s-new-era#u165016Sat, 31 Oct 2026 07:25:23 +0000Moderna CEO Stéphane Bancel detailed the biotech firm's strategic direction following recent clinical trial results for its cancer vaccine, intismeran. Bancel stated that the Cambridge-based company plans to seek Food and Drug Administration approval for the treatment soon. The positive trial outcomes have also bolstered broader industry interest in cancer vaccine strategies involving firms like Merck and Scancell. However, investors have been advised to brace for ongoing financial volatility as the company transitions into its new therapeutic era, even as oncologists praise the promising